Mr. Michael Culme-Seymour has 30 years of logistics experience with airlines, express couriers and major postal companies in Singapore, Zurich and London. He is currently Vice President of Marken, the dedicated Life Science logistics company providing support for the clinical trial industry globally. Mr Culme-Seymour oversees the APAC operations spread across 30 countries and serves most of the leading CROs, CMOs and Pharmaceutical companies. Marken was recently acquired by UPS to be continued to run as a specialist logistics company.

Prior to that, Mr Culme-Seymour held senior executive positions in various companies including Deutsche Post Global Mail, DHL, Swissair and was based in Germany, Switzerland and Asia. He is British with 25 years overseas service with 18 of these based in Singapore with regional roles. Before his corporate career, he served with the Royal Navy for 6 years and is a passionate photographer.

 
Presentation Synopsis
Innovative Technologies for Clinical Trial Logistics
The Singapore government has recently announced that the focus on future healthcare has to include more “home care’ to meet the “graying” population. How does this play out in terms of keeping patients enrolled in clinical trials whilst remaining in the comfort of their own home?

Marken is already tackling the challenges – and advantages of providing both investigational drug delivery to patients’ homes and ensuring that blood and other biological samples are collected and transported safely to the central labs, often based thousands of miles away overseas.

The rise of personalised medicine, often involving Cell & Gene Therapy has demanded that logistics companies come up with highly sophisticated solutions to transport biological samples, often at deep frozen temperatures, across international boundaries – and back within a very short time frame. Marken has designed tailor made solutions to suit all therapeutic cell modification logistics, however complicated it can be.